User Experiences of the Cue2walk Smart Cueing Device for Freezing of Gait in People with Parkinson’s Disease
Sensors · 2025
DOI: 10.3390/s25154702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2025. Verfasst von Matthijs van der Laan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Amsterdam University Medical Center, 1081 HZ Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Parkinson Disease, Wearable Electronic Devices, Gait, Gait Disorders, Neurologic. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
Freezing of gait (FoG) impairs mobility and daily functioning and increases the risk of falls, leading to a reduced quality of life (QoL) in people with Parkinson’s disease (PD). The Cue2walk, a wearable smart cueing device, can detect FoG and hereupon provides rhythmic cues to help people with PD manage FoG in daily life. This study investigated the user experiences and device usage of the Cue2walk, and its impact on health-related QoL, FoG and daily activities. Twenty-five users of the Cue2walk were invited to fill out an online survey, which included a modified version of the EQ-5D-5L, tailored to the use of the Cue2walk, and its scale for health-related QoL, three FoG-related questions, and a question about customer satisfaction. Sixteen users of the Cue2walk completed the survey. Average device usage per day was 9 h (SD 4). Health-related QoL significantly increased from 5.2/10 (SD 1.3) to 6.2/10 (SD 1.3) (p = 0.005), with a large effect size (Cohen’s d = 0.83). A total of 13/16 respondents reported a positive effect on FoG duration, 12/16 on falls, and 10/16 on daily activities and self-confidence. Customer satisfaction was 7.8/10 (SD 1.7). This pilot study showed that Cue2walk usage per day is high and that 15/16 respondents experienced a variety of positive effects since using the device. To validate these findings, future studies should include a larger sample size and a more extensive set of questionnaires and physical measurements monitored over time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Amsterdam University Medical Center, 1081 HZ Amsterdam, The Netherlands.
- Amsterdam Movement Sciences, Rehabilitation & Development, 1081 HZ Amsterdam, The Netherlands.
- Cue2Walk International B.V., 2521 AL The Hague, The Netherlands.
- Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Rehabilitation, Centre of Expertise for Parkinson & Movement Disorders, 6525 GA Nijmegen, The Netherlands.
- Department of Rehabilitation, Sint Maartenskliniek, 6574 NA Nijmegen, The Netherlands.
ORCID-Profile: Matthijs van der Laan, Marc B Rietberg, Martijn van der Ent, Vincent de Groot, Jorik Nonnekes, Erwin E H van Wegen
Förderung
- ZonMw
Zitieren
APA
van der Laan, M., Rietberg, M. B., van der Ent, M., Waardenburg, F., de Groot, V., Nonnekes, J., & van Wegen, E. E. H. (2025). User Experiences of the Cue2walk Smart Cueing Device for Freezing of Gait in People with Parkinson’s Disease. Sensors. https://doi.org/10.3390/s25154702
Vancouver
van der Laan M, Rietberg MB, van der Ent M, Waardenburg F, de Groot V, Nonnekes J, et al. User Experiences of the Cue2walk Smart Cueing Device for Freezing of Gait in People with Parkinson’s Disease. Sensors. 2025. doi:10.3390/s25154702
BibTeX
@article{vanderLaan2025,
author = {van der Laan, Matthijs and Rietberg, Marc B and van der Ent, Martijn and Waardenburg, Floor and de Groot, Vincent and Nonnekes, Jorik and van Wegen, Erwin E H},
title = {User Experiences of the Cue2walk Smart Cueing Device for Freezing of Gait in People with Parkinson’s Disease},
journal = {Sensors},
year = {2025},
doi = {10.3390/s25154702}
}
EUVIMED